References
- Alander M, Mättö J, Kneifel W, Johansson M, Kögler B, Crittenden R, Mattila-Sandholm T, Saarela M. Effects of galacto-oligosaccharide supplementation on human faecal microflora and on survival and persistence of Bifidobacterium lactis Bb-12 in the gastrointestinal tract. Int Dairy J 2001; 11: 817–825
- Bednar GE, Patil AR, Murray SM, Grieshop CM, Merchen NR, Fahey GC. Starch and fiber fractions in selected food and feed ingredients affect their small intestinal digestibility and fermentability and their large bowel fermentability in vitro in a canine model. J Nutr 2001; 131: 276–286
- Biedrzycka E, Bielecka M, Amarowicz R. The effect of intestinal microflora on antioxidant activity of apple juice. J Food Lipids 2005; 12: 261–274
- Boehm G, Stahl B, Jelinek J, Knol J, Miniello V, Moro GE. Prebiotic carbohydrates in human milk and formulas. Acta Paediatr 2005; 94(Suppl 449)18–21
- Champ M, Martin L, Noah L, Gratas M. Analytical methods for resistant starch. Complex carbohydrates in food, S Sungsoo Cho, L Prosky, M Dreher. Marcel Dekker, Inc, New York 1999; 184–187
- Crittenden RG, Morris LF, Harvey ML, Tran LT, Mitchell HL, Playne MJ. Selection of Bifidobacterium strain to complement resistant starch in a synbiotic yoghurt. J Appl Microbiol 2001; 90(2)268–278
- Cummings JH, Macfarlane GT. The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 1991; 70: 443–459
- Gibson RG, Roberfroid MB. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr 1995; 125: 1401–1412
- Gibson GR, Willems A, Reading S, Collins MD. Fermentation of non-digestible oligosaccharides by human colonic bacteria. Proc Nutr Soc 1996; 55: 899–912
- Jarowrenko W. Pregelatinised starches. Modified starches: Properties and uses, OB Wurzburg. CRC Press, Boca Raton, FL 1986; 71
- Lewandowicz G, Soral-Śmietana M. Starch modification by iterated syneresis. Carbohydr Polym 2004; 56: 403–413
- Lewandowicz G Soral-Śmietana M Fornal J 2004. Sposób otrzymywania spożywczego preparatu skrobiowego o podwyzszonej odporności na enzymy amylolityczne [The way of receiving alimentary starch preparation with increased resistance to amylolytic enzymes]. Polish patent P.325981.
- Nugent AP. Health properties of resistant starch. Nutr Bull 2005; 30: 27–54
- Raghupathy P, Ramakrishna BS, Oommen SP, Ahmed MS, Priyaa G, Dziura J, Young GP, Binder HJ. Amylase-resistant starch as adjunct to oral rehydration therapy in children with diarrhea. J Pediatr Gastroenterol Nutr 2006; 42: 362–368
- Schmelzle H, Wirth S, Skopnik H, Radke M, Knol J, Böckler HM, Brönstrup A, Wells J, Fusch Ch. Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolysed protein, a high β-palmitic acid level, and nondigestible oligosaccharides. J Pediatr Gastroenterol Nutr 2003; 36: 343–351
- Sijilata MG, Singhal RS, Kulkarni PR. Resistant starch—A review. Comprehens Rev Food Sci Food Safety 2006; 5: 1–17
- Soral-Śmietana M, Wronkowska M. Resistant starch—Nutritional and biological activity. Polish J Food Nutr Sci 2004; 13/54(SI 1)51–64
- Soral-Śmietana M, Wronkowska M, Biedrzycka E, Bielecka M, Ocicka K. Native and physically-modified starches—Utilization of resistant starch by bifidobacteria (in vitro). Polish J Food Nutr Sci 2005; 14/55(3)273–279
- Topping DL, Fukushima M, Bird AR. Resistant starch as a prebiotic and synbiotic: State of the art. Proc Nutr Soc 2003; 62: 171–176
- Wang X, Conway PL, Brown IL, Evans AJ. In vitro utilization of amylopectin and high-amylose maize (amylomaize) starch granules by human colonic bacteria. J Appl Microbiol 1999; 87: 631–639